In a 15‑year‑old male with a known groin tinea cruris, does a similar rash on the face represent tinea cruris or a different dermatophyte infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, a rash on the face is NOT tinea cruris

Tinea cruris, by definition, is a dermatophyte infection of the groin, inner thighs, and buttocks—it cannot occur on the face. A similar-appearing rash on the face in your 15-year-old patient with known groin tinea cruris represents a separate dermatophyte infection, most appropriately termed tinea faciei (or tinea corporis of the face).

Understanding the Terminology

Dermatophyte infections are classified by anatomical location:

  • Tinea cruris = groin/inner thighs
  • Tinea corporis = body (trunk, limbs)
  • Tinea faciei = face (excluding beard area)
  • Tinea capitis = scalp
  • Tinea pedis = feet

The same dermatophyte species can cause infections at multiple body sites simultaneously, but each site receives its own diagnostic term 1, 2.

Clinical Implications for Your Patient

This represents autoinoculation or spread of the same dermatophyte from the groin to the face, likely through contaminated hands or towels. The most probable causative organism is Trichophyton rubrum, which accounts for the majority of both tinea cruris and tinea corporis/faciei cases 1, 3.

Key Diagnostic Considerations:

  • Confirm the diagnosis: Facial dermatophyte infections can mimic numerous conditions including lupus erythematosus, rosacea, eczematous dermatitis, and polymorphous light eruption 4. The COVID-19 pandemic has increased tinea faciei cases due to prolonged mask-wearing 1.

  • Look for classic features: Annular erythematous plaques with scaling and an active advancing border are typical 3. However, facial tinea can present atypically, especially if corticosteroids have been applied 4, 5.

  • Obtain mycological confirmation: Scrape scales from the active border for KOH microscopy and fungal culture, particularly since facial rashes have a broad differential diagnosis 2.

Treatment Approach

For a 15-year-old with both groin and facial involvement, systemic antifungal therapy is indicated rather than topical therapy alone, given the multiple sites of infection 2.

Recommended Treatment:

Oral terbinafine 250 mg daily for 2-4 weeks is first-line therapy for Trichophyton species infections (the most likely pathogen) 6, 1, 2. This will treat both the groin and facial infections simultaneously.

Alternative options include:

  • Itraconazole 100-200 mg daily for 2-4 weeks (effective against both Trichophyton and Microsporum species) 6
  • Topical antifungals may be added as adjunctive therapy but should not be used alone for multiple-site infections 7

Critical Management Points:

  • Screen household contacts: Family members should be examined for dermatophyte infections, as 70% of patients report contact with infected family members 3

  • Address fomite sharing: 83% of patients share towels, clothing, or other items—counsel on avoiding this practice 3

  • Avoid corticosteroid-antifungal combinations: These are not recommended despite potentially faster symptom relief, as they can lead to atypical presentations and treatment resistance 4, 5, 2

  • Confirm mycological cure: Clinical improvement may precede mycological clearance. Consider repeat sampling if symptoms persist or recur 6

Common Pitfall to Avoid:

Do not assume the facial rash is "just tinea cruris spreading"—it requires its own diagnostic consideration and proper terminology. More importantly, facial involvement suggests either significant autoinoculation or potentially an emerging resistant strain (such as T. indotineae or T. mentagrophytes genotype VII), which may require prolonged therapy and specialized testing if first-line treatment fails 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.